Ousseny Zerbo

Ousseny Zerbo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ousseny Zerbo sits on this spectrum.

Ousseny Zerbo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ousseny Zerbo sits on this spectrum.

Best Publications

• Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

  Unknown

  789
  Citations

• Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

  Unknown

  761
  Citations

• Surveillance for Adverse Events After COVID-19 mRNA Vaccination.

  Nicola P Klein;Ned Lewis;Kristin Goddard;Bruce Fireman

  599
  Citations

• Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.

  Mark G Thompson;Edward Stenehjem;Shaun Grannis;Sarah W Ball

  469
  Citations

• Is Maternal Influenza or Fever During Pregnancy Associated with Autism or Developmental Delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study

  Ousseny Zerbo;Ousseny Zerbo;Ana-Maria Iosif;Cheryl Walker;Sally J Ozonoff

  368
  Citations

• Maternal Infection During Pregnancy and Autism Spectrum Disorders.

  Ousseny Zerbo;Yinge Qian;Cathleen Yoshida;Judith K. Grether

  335
  Citations

• Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

  Unknown

  319
  Citations

• Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

  Unknown

  298
  Citations

• Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation.

  K L Jones;L A Croen;C K Yoshida;L Heuer

  278
  Citations

• Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

  Unknown

  208
  Citations

• COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021.

  Hilda Razzaghi;Mehreen Meghani;Cassandra Pingali;Bradley Crane

  190
  Citations

• Immune mediated conditions in autism spectrum disorders.

  Ousseny Zerbo;Albin Leong;Lisa Barcellos;Pilar Bernal

  189
  Citations

• Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.

  Peter J Embi;Matthew E Levy;Allison L Naleway;Palak Patel

  184
  Citations

• Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

  Unknown

  183
  Citations

• Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder.

  Ousseny Zerbo;Yinge Qian;Cathleen Yoshida;Bruce H. Fireman

  149
  Citations

• Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

  Unknown

  130
  Citations

• Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: The Early Markers for Autism (EMA) study: A case-control study

  Ousseny Zerbo;Cathleen Yoshida;Judith K. Grether;Judith K. Grether;Judith A Van de Water

  128
  Citations

• Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

  Unknown

  107
  Citations

• Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.

  Catherine H Bozio;Shaun J Grannis;Allison L Naleway;Toan C Ong

  93
  Citations

• Infection and Fever in Pregnancy and Autism Spectrum Disorders: Findings from the Study to Explore Early Development.

  Lisa A. Croen;Yinge Qian;Paul Ashwood;Ousseny Zerbo

  92
  Citations